€
4. 44
+0.05
+1.139%
€
138.04M Market Cap
- P/E Ratio
- Div Yield
201 Volume
0 Eps
€ 4.39
Previous Close Want to track 52U and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hyloris Pharmaceuticals SA (52U) Statistics
Valuation metrics
Market Cap 138.04M
Enterprise value 125.88M
Trailing P/E (ttm) -21.43
Forward P/E -
PEG ratio -
Price/Sales (ttm) 17.39
Price/Book (mrq) 5.21
Enterprise Value/Revenue 15.86
Enterprise Value/EBITDA -15.68
Overview
Shares outstanding 28M
Float 11.47M
Shares short -
% Held by insiders 0.58%
% Held by institutions 0%
Average volume (10 days) 270
Average volume (90 days) 100
Price summary
52-Week low 4.25
52-Week high 8.14
Beta 0.65
50-Day moving average 5.07
200-Day moving average 5.99
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2020
Profitability
Profit margin -0.8%
Operating margin -1%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.22%
Income Statement
Revenue (ttm) 7.94M
Revenue per share (ttm) 0.28
Quarterly revenue growth (yoy) -0.1%
Gross profit (ttm) 7.56M
EBITDA -8.03M
Net income to common (ttm) -6.33M
Diluted EPS (ttm) -0.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 13.78M
Total cash per share (mrq) 0.49
Total debt (mrq) 1.61M
Total Debt/Equity (mrq) 6.08
Current ratio (mrq) 3.89%
Book value per share (mrq) 0.95
Cash Flow
Cash flow statement -6.99M
Levered free cash flow (LFCF) -6.51M
